Stay updated on Upadacitinib in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T00:52:01.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the upadacitinib atopic dermatitis study is now displayed, including its study design, eligibility criteria, outcome measures, locations, publications, and supporting documents.
    Difference
    100%
    Check dated 2026-11-10T19:11:49.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T19:21:13.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    An NIH-wide notice about website terminology changes was added, and the site revision advanced from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden message instead of the study record.
    Difference
    1%
    Check dated 2026-10-20T19:46:28.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:04:45.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown in place of the study record, with the site header/footer visible and a Home link available, indicating restricted access rather than the study details.
    Difference
    0.5%
    Check dated 2026-09-29T19:44:01.000Z thumbnail image

Stay in the know with updates to Upadacitinib in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Atopic Dermatitis Clinical Trial page.